Literature DB >> 16517916

Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin.

John R Ticehurst1, Deborah Z Aird, Lisa M Dam, Anita P Borek, John T Hargrove, Karen C Carroll.   

Abstract

We evaluated a two-step algorithm for detecting toxigenic Clostridium difficile: an enzyme immunoassay for glutamate dehydrogenase antigen (Ag-EIA) and then, for antigen-positive specimens, a concurrent cell culture cytotoxicity neutralization assay (CCNA). Antigen-negative results were > or = 99% predictive of CCNA negativity. Because the Ag-EIA reduced cell culture workload by approximately 75 to 80% and two-step testing was complete in < or = 3 days, we decided that this algorithm would be effective. Over 6 months, our laboratories' expenses were US dollar 143,000 less than if CCNA alone had been performed on all 5,887 specimens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517916      PMCID: PMC1393084          DOI: 10.1128/JCM.44.3.1145-1149.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Practice guidelines for the management of infectious diarrhea.

Authors:  R L Guerrant; T Van Gilder; T S Steiner; N M Thielman; L Slutsker; R V Tauxe; T Hennessy; P M Griffin; H DuPont; R B Sack; P Tarr; M Neill; I Nachamkin; L B Reller; M T Osterholm; M L Bennish; L K Pickering
Journal:  Clin Infect Dis       Date:  2001-01-30       Impact factor: 9.079

Review 2.  Clostridium difficile testing: after 20 years, still challenging.

Authors:  Tracy D Wilkins; David M Lyerly
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

3.  Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.

Authors:  Heather Snell; Meredith Ramos; Sue Longo; Michael John; Zafar Hussain
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

4.  Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.

Authors:  Scott D Lee; David K Turgeon; Cynthia W Ko; Thomas R Fritsche; Christina M Surawicz
Journal:  Am J Gastroenterol       Date:  2003-07       Impact factor: 10.864

5.  Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.

Authors:  C S Merz; C Kramer; M Forman; L Gluck; K Mills; K Senft; I Steiman; N Wallace; P Charache
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

6.  Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase.

Authors:  D M Lyerly; L A Barroso; T D Wilkins
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

Review 7.  Clostridium difficile-associated diarrhea in adults.

Authors:  Susan M Poutanen; Andrew E Simor
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

8.  The lack of value of repeated Clostridium difficile cytotoxicity assays.

Authors:  A A Renshaw; J M Stelling; M H Doolittle
Journal:  Arch Pathol Lab Med       Date:  1996-01       Impact factor: 5.534

9.  Clostridium difficile colitis: an efficient clinical approach to diagnosis.

Authors:  Y C Manabe; J M Vinetz; R D Moore; C Merz; P Charache; J G Bartlett
Journal:  Ann Intern Med       Date:  1995-12-01       Impact factor: 25.391

10.  Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens.

Authors:  L Zheng; S F Keller; D M Lyerly; R J Carman; C W Genheimer; C A Gleaves; S J Kohlhepp; S Young; S Perez; K Ye
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

View more
  55 in total

1.  Laboratory diagnosis of Clostridium difficile infection.

Authors:  S D Goldenberg; P R Cliff; G L French
Journal:  J Clin Microbiol       Date:  2010-08       Impact factor: 5.948

2.  Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.

Authors:  Tess Karre; Lynne Sloan; Robin Patel; Jayawant Mandrekar; Jon Rosenblatt
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

3.  Diagnostic algorithm using a sensitive broth culture method for detection of Clostridium difficile toxin from stool samples.

Authors:  Paul Bayardelle
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

4.  Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system.

Authors:  Alex B Ryder; Ying Huang; Haijing Li; Min Zheng; Xiaobo Wang; Charles W Stratton; Xiao Xu; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

Review 5.  Recognition and prevention of hospital-associated enteric infections in the intensive care unit.

Authors:  Linda D Bobo; Erik R Dubberke
Journal:  Crit Care Med       Date:  2010-08       Impact factor: 7.598

6.  Clostridium difficile outbreaks.

Authors:  Paul Bayardelle
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-11       Impact factor: 2.471

7.  Evaluation of diagnostic tests for Clostridium difficile infection.

Authors:  Jonathan Swindells; Nigel Brenwald; Nathan Reading; Beryl Oppenheim
Journal:  J Clin Microbiol       Date:  2009-12-23       Impact factor: 5.948

8.  C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens.

Authors:  Criziel D Quinn; Susan E Sefers; Wisal Babiker; Ying He; Romina Alcabasa; Charles W Stratton; Karen C Carroll; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

Review 9.  Treatment of refractory and recurrent Clostridium difficile infection.

Authors:  Christina M Surawicz; Jacob Alexander
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04-19       Impact factor: 46.802

10.  Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.

Authors:  Paul D Stamper; Romina Alcabasa; Deborah Aird; Wisal Babiker; Jennifer Wehrlin; Ijeoma Ikpeama; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.